Mass spectrometry market to rise at 12.26% CAGR through 2028

Thanks to an increased investment in pharmaceutical and biopharmaceuticals.

The global market for mass spectrometry is projected to grow by $3.52b until 2028 at an estimated compound annual growth rate (CAGR) of over 12.26%, according to Technavio.

The sector is witnessing a notable expansion due to an increased investment in pharmaceuticals and biopharmaceuticals, driven by a focus on drug safety and a demand for precise diagnostic tools.

“Mass spectrometers play a crucial role in personalised medicine by screening biomarkers for disease phenotypes, enabling targeted drug development and individualised therapy,” the report said.

In line with this, key areas such as metabolomics and vaccine development are rising as research fields in the sector.

Moreover, new opportunities are growing in emerging countries and greenfield projects, requiring skilled professionals for method development and system operation.